Australia Wealth Fund Posts Biggest Quarterly Loss in Two Years
(Bloomberg) -- Australia's sovereign wealth fund suffered its largest quarterly loss in two years amid renewed geopolitical and monetary policy risks.
Future Fund lost 1.5% in the three months to March 31, the biggest drop since the same period in 2020, causing its main fund to shrink to A$201 billion ($141 billion) from A$204 billion, it said in statement Monday. At the same time, the fund reduced its cash holdings as allocation into Australian and developed market stocks and so-called alternative assets increased, the statement said.
“As central banks tighten monetary policy to rein in inflation and geopolitical tensions continue to create shocks in investment markets, we have been positioning for what will be a challenging and volatile future,” Future Fund Chairman Peter Costello said in a statement.
The Future Fund was warning of a worsening global outlook even before Russia's aggression toward Ukraine, anticipating an increase in volatility as central banks remove stimulus and lift borrowing costs to combat rising consumer cost pressures. It trimmed its stock allocation in December, helping to cushion the impact during a turbulent quarter for global equities.
Future Fund Chief Executive Raphael Arndt warned future returns will be harder to achieve given the ongoing fragility in global markets combined with rising inflation. That echoed Norway's wealth fund, the world's largest, which recorded a 4.9% quarterly loss in March. The Future Fund is hunting more unlisted assets while relying on its alternative strategies to cushion the portfolio, he said.
Australia's wealth fund decided on Feb. 28 to drop Russian assets in response to the country's invasion of Ukraine, but ran into problems with implementing the decision after Russia banned foreigners from executing trades on its stock markets. The fund, which had about A$180 million of Russian assets at April 5, will wind down the holdings as market conditions allow, Costello said.
©2022 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.